With the viruses and timing constantly evolving, keeping current can be a daunting task. So, we’re pleased to invite you to attend Updates on Influenza, COVID-19 and RSV: Trends and Treatments, a free webinar scheduled for Friday, October 27th at 2pm, EST. Lindsey E. Fish, MD will lead an expansive discussion of the epidemiology of the viruses, as well as their timely diagnosis, treatment guidelines, and predictions for the 2023-2024 season.

Watch this webinar for a dive deep into the world of antigen vs. molecular laboratory testing and discover the perfect fit for your Urgent Care setting. Navigate the maze of testing pitfalls, debunk common myths, and tailor your approach for optimal patient care. Whether you’re battling respiratory bugs or tackling STIs, ensure you’re equipped with the best testing strategies and elevate your diagnostic game.

The threat of SARS-CoV-2 has slowed considerably, STIs are back in full force – with a vengeance. Urgent care clinics are a likely go-to option, providing quality care in an efficient and convenient manner—and the added benefit of relative anonymity. Incorporating point-of-care PCR testing for STI can bring speed to diagnosis and STI management in Urgent Care settings.

STIs are currently at historic highs in the US, with epidemic increases observed for both gonorrhea and syphilis. STI expert and author Ina Park, MD, MS will discuss the latest disease trends in STI incidence and antibiotic resistance, as well as CDC guidelines for diagnosis and treatment of the most common STIs seen in urgent care settings.

Infectious disease expert Gary Schoolnik, MD will present recent advances in point-of-care testing for sexually transmitted infections, in particular a CLIA waived, rapid PCR test that provides both accuracy and speed of results at the point of care – no instrument required. Such advancements for STI enables Urgent Care clinicians to make results-driven diagnoses for correct treatment while the patient is still at the clinic visit, for improved patient experience and clinician satisfaction.

With both viruses constantly evolving, keeping current can be a daunting task. Lindsey E. Fish, MD will lead an expansive discussion of the epidemiology of both viruses, as well as their timely diagnosis, trends in treatment, and emerging guidelines.

Assess your preparedness and glean new insights from an expert in the field with this webinar hosted by JUCM and led by Glenn Harnett MD. The presentation will be followed by a live Q&A session. JUCM invites you to attend at no charge thanks to the sponsorship of Visby Medical.

Adolescents often present with vague symptoms for sexually transmitted infections (STIs). A majority are underrecognized and untreated at the time of presentation. Also, a large proportion is lost to follow-up. This webinar will discuss testing methods for detecting common STIs and patient education strategies to reduce recurrence.

Trichomoniasis, the most common non-viral sexually transmitted infection, is underdiagnosed due to lack of screening, surveillance, and control programs. The most commonly used diagnostic test lacks sensitivity. Undertreating trichomoniasis can lead to adverse health outcomes and persistence of infection in sexual networks. This webinar evaluates a modern approach to managing this neglected disease.

Adoption of innovative POC STI testing allows for superior patient care, precise use of antibiotics for treatment, and adds an opportunity to provide counseling and preventive measures. Patients benefit from the right treatment for the right problem, and experience less anxiety and distress. Practices benefit from the speed and accuracy of testing, which results in staff efficiency of care and less time charting, allowing for more patient encounters.

In addition to providing updates on epidemiology, clinical relevance, and treatment recommendations, this webinar will examine the challenges associated with Trichomonas diagnosis, discuss issues surrounding drug resistance, and review patient management including the 2021 CDC guidelines for Trichomonas testing & treatment.

On December 9, 2021, NACCHO, the National Coalition of STD Directors (NCSD), and the National Association of State and Territorial AIDS Directors (NASTAD) hosted a webinar on a new point-of-care technology for testing of sexually transmitted infections (STIs) and the impact of its use for health departments.

This webinar will present the 2021 CDC STI guidelines, dive into the challenges with traditional STI testing and the impact on antibiotic stewardship and review what is needed to combat the growing number of antibiotic resistant STI.